Literature DB >> 32016077

Toxicity of pelvic nodal radiation for localized prostate cancer.

Waqar Haque1, E Brian Butler1, Bin S Teh1.   

Abstract

Entities:  

Year:  2019        PMID： 32016077      PMCID： PMC6976416          DOI： 10.21037/atm.2019.09.57

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  12 in total

1.  Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

Authors:  Miljenko V Pilepich; Kathryn Winter; Colleen A Lawton; Robert E Krisch; Harvey B Wolkov; Benjamin Movsas; Eugen B Hug; Sucha O Asbell; David Grignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

2.  Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06.

Authors:  S O Asbell; J M Krall; M V Pilepich; H Baerwald; W T Sause; G E Hanks; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-12       Impact factor: 7.038

3.  Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.

Authors:  Michael Pinkawa; Marc D Piroth; Richard Holy; Karin Fischedick; Jens Klotz; Dalma Székely-Orbán; Michael J Eble
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-09       Impact factor: 7.038

4.  Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Authors:  Curtiland Deville; Stefan Both; Wei-Ting Hwang; Zelig Tochner; Neha Vapiwala
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-18       Impact factor: 7.038

5.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  J Urol       Date:  2019-03       Impact factor: 7.450

6.  Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.

Authors:  Pascal Pommier; Sylvie Chabaud; Jean-Leon Lagrange; Pierre Richaud; Elisabeth Le Prise; Jean-Philippe Wagner; David Azria; Veronique Beckendorf; Jean-Philippe Suchaud; Valerie Bernier; David Perol; Christian Carrie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-15       Impact factor: 7.038

7.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer.

Authors:  Nathan C Sheets; Gregg H Goldin; Anne-Marie Meyer; Yang Wu; YunKyung Chang; Til Stürmer; Jordan A Holmes; Bryce B Reeve; Paul A Godley; William R Carpenter; Ronald C Chen
Journal:  JAMA       Date:  2012-04-18       Impact factor: 56.272

8.  Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

Authors:  Mack Roach; Kyounghwa Bae; Joycelyn Speight; Harvey B Wolkov; Phillip Rubin; R Jeffrey Lee; Colleen Lawton; Richard Valicenti; David Grignon; Miljenko V Pilepich
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

9.  An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions.

Authors:  Colleen A Lawton; Michelle DeSilvio; Mack Roach; Valery Uhl; Robert Kirsch; Michael Seider; Marvin Rotman; Christopher Jones; Sucha Asbell; Richard Valicenti; Stephen Hahn; Charles R Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-24       Impact factor: 7.038

10.  Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma.

Authors:  Ayal A Aizer; James B Yu; Anne M McKeon; Roy H Decker; John W Colberg; Richard E Peschel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-21       Impact factor: 7.038
View more
  1 in total

1.  Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation.

Authors:  Srinivas Chilukuri; Sham Sundar; Kartikeswar Patro; Mayur Sawant; Rangasamy Sivaraman; Manikandan Arjunan; Pankaj Kumar Panda; Dayananda Sharma; Rakesh Jalali
Journal:  Int J Part Ther       Date:  2022-06-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.